UCL  IRIS
Institutional Research Information Service
UCL Logo
Please report any queries concerning the funding data grouped in the sections named "Externally Awarded" or "Internally Disbursed" (shown on the profile page) to your Research Finance Administrator. Your can find your Research Finance Administrator at http://www.ucl.ac.uk/finance/research/post_award/post_award_contacts.php by entering your department
Please report any queries concerning the student data shown on the profile page to:

Email: portico-services@ucl.ac.uk

Help Desk: http://www.ucl.ac.uk/ras/portico/helpdesk
Publication Detail
The anti-diabetic drug metformin does not affect bone mass in vivo or fracture healing.
  • Publication Type:
    Journal article
  • Publication Sub Type:
    Journal Article
  • Authors:
    Jeyabalan J, Viollet B, Smitham P, Ellis SA, Zaman G, Bardin C, Goodship A, Roux JP, Pierre M, Chenu C
  • Publication date:
    10/2013
  • Pagination:
    2659, 2670
  • Journal:
    Osteoporos Int
  • Volume:
    24
  • Issue:
    10
  • Country:
    England
  • Language:
    eng
  • Keywords:
    AMP-Activated Protein Kinases, Animals, Bone Density, Bone Remodeling, Bony Callus, Enzyme Activation, Female, Femoral Fractures, Femur, Fracture Healing, Hypoglycemic Agents, Metformin, Mice, Mice, Inbred C57BL, Osteoporosis, Ovariectomy, Rats, Rats, Wistar, Tibia, X-Ray Microtomography
Abstract
The present study shows no adverse effects of the anti-diabetic drug metformin on bone mass and fracture healing in rodents but demonstrates that metformin is not osteogenic in vivo, as previously proposed.
Publication data is maintained in RPS. Visit https://rps.ucl.ac.uk
 More search options
UCL Researchers
Author
Dept of Med Phys & Biomedical Eng
Author
Inst of Orthopaedics & Musculosk Sci
University College London - Gower Street - London - WC1E 6BT Tel:+44 (0)20 7679 2000

© UCL 1999–2011

Search by